These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21241803)

  • 1. Inhibition of T-cell activation and proliferation by mycophenolic acid in patients awaiting liver transplantation: PK/PD relationships.
    Prémaud A; Rousseau A; Johnson G; Canivet C; Gandia P; Muscari F; Peron JM; Rostaing L; Marquet P; Kamar N
    Pharmacol Res; 2011 May; 63(5):432-8. PubMed ID: 21241803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
    Gummert JF; Barten MJ; Sherwood SW; van Gelder T; Morris RE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1100-12. PubMed ID: 10565830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients.
    Minmin S; Zhidong G; Hao C; Weixia Z; Baiyong S; Bing C; Chuan S; Xiaxing D; Xi Z
    J Clin Pharmacol; 2010 Dec; 50(12):1388-96. PubMed ID: 20220042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic evaluation of the first dose of mycophenolate mofetil before kidney transplantation.
    Kamar N; Glander P; Nolting J; Böhler T; Hambach P; Liefeldt L; Rostaing L; Neumayer HH; Budde K
    Clin J Am Soc Nephrol; 2009 May; 4(5):936-42. PubMed ID: 19339413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients.
    Böhler T; Canivet C; Galvani S; Therville N; Salvayre R; Negre-Salvayre A; Durand D; Thomsen M; Rostaing L; Kamar N
    Int Immunopharmacol; 2008 May; 8(5):769-73. PubMed ID: 18387521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.
    Gummert JF; Barten MJ; van Gelder T; Billingham ME; Morris RE
    Transplantation; 2000 Oct; 70(7):1038-49. PubMed ID: 11045640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of mycophenolate mofetil monotherapy on T-cell functions and inosine monophosphate dehydrogenase activity in patients undergoing a kidney transplantation.
    Kamar N; Glander P; Nolting J; Böhler T; Hambach P; Liefeldt L; Neumayer HH; Klupp J; Budde K
    Transplant Proc; 2006 Sep; 38(7):2292-4. PubMed ID: 16980068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of mycophenolic acid on cell cycle and activation of human lymphocytes.
    Heinschink A; Raab M; Daxecker H; Griesmacher A; Müller MM
    Clin Chim Acta; 2000 Oct; 300(1-2):23-8. PubMed ID: 10958860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualizing combination of two antiproliferative immunosuppressants with pharmacodynamic modeling of stimulated lymphocyte responses.
    Berry V; Magill A; Yost M; Janosky J; Sindhi R
    Cytometry A; 2006 Feb; 69(2):95-103. PubMed ID: 16369935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigations on the immunosuppressive activity of derivatives of mycophenolic acid in immature dendritic cells.
    Iwaszkiewicz-Grzes D; Cholewinski G; Kot-Wasik A; Trzonkowski P; Dzierzbicka K
    Int Immunopharmacol; 2017 Mar; 44():137-142. PubMed ID: 28092865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responsiveness in stable kidney transplantation patients: Complete inhibition of T-cell proliferation but residual T-cell activity during maintenance immunosuppressive treatment.
    In 't Veld AE; Eveleens Maarse BC; Juachon MJ; Meziyerh S; de Vries APJ; van Rijn AL; Feltkamp MCW; Moes DJAR; Burggraaf J; Moerland M
    Clin Transl Sci; 2024 Jun; 17(6):e13860. PubMed ID: 38923308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tabebuia avellanedae extracts inhibit IL-2-independent T-lymphocyte activation and proliferation.
    Böhler T; Nolting J; Gurragchaa P; Lupescu A; Neumayer HH; Budde K; Kamar N; Klupp J
    Transpl Immunol; 2008 Feb; 18(4):319-23. PubMed ID: 18158117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolic acid inhibits natural killer cell proliferation and cytotoxic function: a possible disadvantage of including mycophenolate mofetil in the graft-versus-host disease prophylaxis regimen.
    Ohata K; Espinoza JL; Lu X; Kondo Y; Nakao S
    Biol Blood Marrow Transplant; 2011 Feb; 17(2):205-13. PubMed ID: 20736080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyoma BK virus-associated nephropathy in kidney-transplant patients: Effects of leflunomide on T-cell functions and disease outcome.
    Canivet C; Rostaing L; Galvani S; Böhler T; Gandia P; Mengelle C; Guilbeau-Frugier C; Thomsen M; Salvayre R; Negre-Salvayre A; Kamar N
    Int Immunopharmacol; 2009 Aug; 9(9):1131-6. PubMed ID: 19446045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolic acid and methotrexate inhibit lymphocyte cytokine production via different mechanisms.
    de Lathouder S; Gerards AH; de Groot ER; Valkhof M; Aarden LA
    Eur Cytokine Netw; 2002; 13(3):317-23. PubMed ID: 12231475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans.
    Böhler T; Nolting J; Kamar N; Gurragchaa P; Reisener K; Glander P; Neumayer HH; Budde K; Klupp J
    Ther Drug Monit; 2007 Feb; 29(1):77-86. PubMed ID: 17304154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant.
    Zicheng Y; Weixia Z; Hao C; Hongzhuan C
    Ther Drug Monit; 2007 Apr; 29(2):207-14. PubMed ID: 17417076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.
    Bullingham RE; Nicholls A; Hale M
    Transplant Proc; 1996 Apr; 28(2):925-9. PubMed ID: 8623466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil.
    Brunet M; Cirera I; Martorell J; Vidal E; Millán O; Jiménez O; Rojo I; Londoño MC; Rimola A
    Transplantation; 2006 Feb; 81(4):541-6. PubMed ID: 16495801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.